Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychomotor Performance | 27 | 2012 | 492 | 1.470 |
Why?
|
| Oxycodone | 3 | 2012 | 35 | 1.210 |
Why?
|
| Carisoprodol | 2 | 2011 | 4 | 0.820 |
Why?
|
| Narcotics | 3 | 2012 | 69 | 0.820 |
Why?
|
| Analgesics, Opioid | 3 | 2014 | 413 | 0.680 |
Why?
|
| Nitrous Oxide | 17 | 1999 | 107 | 0.540 |
Why?
|
| Muscle Relaxants, Central | 2 | 2011 | 10 | 0.510 |
Why?
|
| Morphine | 3 | 2014 | 130 | 0.510 |
Why?
|
| Cross-Over Studies | 15 | 2014 | 399 | 0.490 |
Why?
|
| Double-Blind Method | 21 | 2014 | 1823 | 0.490 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 143 | 0.470 |
Why?
|
| Naltrexone | 1 | 2014 | 135 | 0.440 |
Why?
|
| Alprazolam | 1 | 2012 | 3 | 0.430 |
Why?
|
| GABA Modulators | 1 | 2012 | 9 | 0.430 |
Why?
|
| Analgesics | 2 | 2011 | 119 | 0.420 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 28 | 0.410 |
Why?
|
| Cognition | 8 | 2011 | 570 | 0.400 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 83 | 0.400 |
Why?
|
| Affect | 16 | 2011 | 386 | 0.380 |
Why?
|
| Anticonvulsants | 1 | 2011 | 126 | 0.380 |
Why?
|
| Memory | 4 | 2012 | 225 | 0.380 |
Why?
|
| Drug Interactions | 6 | 2012 | 248 | 0.320 |
Why?
|
| Emotions | 1 | 2011 | 341 | 0.310 |
Why?
|
| Methionine | 2 | 2019 | 66 | 0.220 |
Why?
|
| Anesthetics, Inhalation | 6 | 1999 | 95 | 0.210 |
Why?
|
| Adult | 30 | 2014 | 25640 | 0.190 |
Why?
|
| Young Adult | 4 | 2014 | 5974 | 0.190 |
Why?
|
| Male | 30 | 2014 | 40956 | 0.160 |
Why?
|
| Narcotic Antagonists | 2 | 2014 | 154 | 0.150 |
Why?
|
| Female | 28 | 2014 | 44507 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2011 | 1961 | 0.140 |
Why?
|
| Pupil | 2 | 2014 | 18 | 0.130 |
Why?
|
| Fentanyl | 3 | 1996 | 65 | 0.130 |
Why?
|
| Propofol | 4 | 1996 | 89 | 0.120 |
Why?
|
| Substance-Related Disorders | 3 | 2011 | 394 | 0.120 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2014 | 79 | 0.120 |
Why?
|
| Receptors, Opioid, mu | 1 | 2014 | 45 | 0.120 |
Why?
|
| Infusions, Intravenous | 2 | 2014 | 429 | 0.120 |
Why?
|
| Humans | 38 | 2019 | 86601 | 0.120 |
Why?
|
| Anesthetics, Intravenous | 3 | 1997 | 41 | 0.110 |
Why?
|
| Toxicity Tests, Acute | 1 | 2011 | 2 | 0.110 |
Why?
|
| Pregabalin | 1 | 2011 | 6 | 0.110 |
Why?
|
| Thinking | 1 | 2012 | 33 | 0.100 |
Why?
|
| Respiratory Rate | 1 | 2011 | 20 | 0.100 |
Why?
|
| Analgesia, Obstetrical | 1 | 1991 | 21 | 0.100 |
Why?
|
| Heart Rate | 1 | 2014 | 492 | 0.100 |
Why?
|
| Reaction Time | 2 | 2012 | 309 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2011 | 224 | 0.100 |
Why?
|
| S-Adenosylmethionine | 2 | 2019 | 15 | 0.100 |
Why?
|
| Neuropsychological Tests | 2 | 2012 | 502 | 0.100 |
Why?
|
| Analgesia | 2 | 1999 | 57 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2011 | 161 | 0.080 |
Why?
|
| Respiration Disorders | 1 | 1989 | 39 | 0.080 |
Why?
|
| Methyl Ethers | 2 | 1999 | 33 | 0.080 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 1999 | 46 | 0.080 |
Why?
|
| Pain Measurement | 4 | 1999 | 321 | 0.080 |
Why?
|
| Surveys and Questionnaires | 4 | 2011 | 2501 | 0.080 |
Why?
|
| Naloxone | 2 | 1999 | 59 | 0.080 |
Why?
|
| Midazolam | 2 | 1996 | 48 | 0.070 |
Why?
|
| Thiopental | 2 | 1997 | 15 | 0.070 |
Why?
|
| Isoflurane | 2 | 1996 | 64 | 0.070 |
Why?
|
| Administration, Inhalation | 7 | 1999 | 188 | 0.060 |
Why?
|
| Mental Recall | 3 | 1995 | 159 | 0.060 |
Why?
|
| Neoplasms | 1 | 2019 | 2897 | 0.060 |
Why?
|
| Anesthesia, Intravenous | 2 | 1996 | 35 | 0.060 |
Why?
|
| S-Adenosylhomocysteine | 2 | 2019 | 9 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 2 | 1996 | 125 | 0.060 |
Why?
|
| Homocysteine | 2 | 2019 | 29 | 0.060 |
Why?
|
| Hemodynamics | 3 | 1996 | 710 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7988 | 0.050 |
Why?
|
| Cold Temperature | 3 | 1996 | 157 | 0.050 |
Why?
|
| Psychomotor Disorders | 2 | 1997 | 20 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 1982 | 269 | 0.050 |
Why?
|
| Anesthetics, Combined | 1 | 1999 | 4 | 0.040 |
Why?
|
| Drug Tolerance | 2 | 1996 | 63 | 0.040 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Anesthesia Recovery Period | 2 | 1996 | 56 | 0.040 |
Why?
|
| Methylation | 2 | 2019 | 251 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 315 | 0.040 |
Why?
|
| Injections, Intravenous | 5 | 1996 | 244 | 0.040 |
Why?
|
| Cell Transformation, Viral | 3 | 1982 | 40 | 0.040 |
Why?
|
| Ethers | 1 | 1997 | 14 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 1997 | 45 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 1996 | 22 | 0.040 |
Why?
|
| Euphoria | 2 | 1995 | 43 | 0.040 |
Why?
|
| Anesthesia, Inhalation | 1 | 1996 | 36 | 0.040 |
Why?
|
| Wakefulness | 1 | 1996 | 134 | 0.030 |
Why?
|
| Flumazenil | 1 | 1995 | 8 | 0.030 |
Why?
|
| Arousal | 2 | 1993 | 170 | 0.030 |
Why?
|
| Pain Threshold | 1 | 1995 | 58 | 0.030 |
Why?
|
| Butorphanol | 1 | 1994 | 9 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 243 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1997 | 266 | 0.030 |
Why?
|
| Simian virus 40 | 3 | 1982 | 35 | 0.030 |
Why?
|
| Motivation | 1 | 1996 | 287 | 0.030 |
Why?
|
| Meperidine | 1 | 1993 | 13 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 2426 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1578 | 0.030 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1993 | 54 | 0.030 |
Why?
|
| Behavior | 1 | 1993 | 85 | 0.030 |
Why?
|
| Medical History Taking | 1 | 1992 | 80 | 0.030 |
Why?
|
| Oxygen | 4 | 1999 | 726 | 0.030 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 1991 | 12 | 0.030 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1991 | 25 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 1992 | 105 | 0.030 |
Why?
|
| Ethanol | 1 | 1993 | 249 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1992 | 332 | 0.020 |
Why?
|
| Alfentanil | 1 | 1989 | 2 | 0.020 |
Why?
|
| Prospective Studies | 4 | 1996 | 4210 | 0.020 |
Why?
|
| Recurrence | 1 | 1989 | 1139 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 1991 | 2378 | 0.020 |
Why?
|
| Pregnancy | 1 | 1991 | 2893 | 0.020 |
Why?
|
| Choice Behavior | 2 | 1997 | 160 | 0.020 |
Why?
|
| Reference Values | 2 | 1994 | 674 | 0.010 |
Why?
|
| Pteroylpolyglutamic Acids | 1 | 1981 | 1 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1981 | 729 | 0.010 |
Why?
|
| Folic Acid | 1 | 1981 | 60 | 0.010 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1981 | 55 | 0.010 |
Why?
|
| Cell Division | 1 | 1982 | 696 | 0.010 |
Why?
|
| Cell Line | 2 | 1982 | 2468 | 0.010 |
Why?
|
| Methyltransferases | 1 | 1981 | 182 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1996 | 1143 | 0.010 |
Why?
|
| Mental Competency | 1 | 1997 | 49 | 0.010 |
Why?
|
| Immersion | 1 | 1996 | 21 | 0.010 |
Why?
|
| Motor Skills | 1 | 1996 | 71 | 0.010 |
Why?
|
| DNA | 1 | 1981 | 1294 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1996 | 153 | 0.010 |
Why?
|
| Informed Consent | 1 | 1997 | 266 | 0.010 |
Why?
|
| Miosis | 1 | 1994 | 10 | 0.010 |
Why?
|
| Reflex, Pupillary | 1 | 1994 | 7 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1996 | 236 | 0.010 |
Why?
|
| Middle Aged | 2 | 1992 | 25017 | 0.010 |
Why?
|
| Patient Discharge | 1 | 1996 | 300 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1996 | 894 | 0.010 |
Why?
|
| Pulse | 1 | 1992 | 18 | 0.010 |
Why?
|
| Attitude to Computers | 1 | 1992 | 12 | 0.010 |
Why?
|
| Preventive Medicine | 1 | 1992 | 17 | 0.010 |
Why?
|
| Pain | 1 | 1995 | 391 | 0.010 |
Why?
|
| Individuality | 1 | 1993 | 109 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 274 | 0.010 |
Why?
|
| Attention | 1 | 1996 | 388 | 0.010 |
Why?
|
| Time Factors | 2 | 1996 | 5209 | 0.010 |
Why?
|
| Anesthesia | 1 | 1993 | 164 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 1992 | 319 | 0.010 |
Why?
|
| Learning | 1 | 1993 | 280 | 0.010 |
Why?
|
| Anesthesiology | 1 | 1992 | 157 | 0.010 |
Why?
|
| Health Status | 1 | 1992 | 360 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1992 | 394 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 3636 | 0.010 |
Why?
|
| gamma-Glutamyl Hydrolase | 1 | 1981 | 1 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1981 | 103 | 0.000 |
Why?
|
| Cytosine | 1 | 1981 | 127 | 0.000 |
Why?
|
| 5-Methylcytosine | 1 | 1981 | 112 | 0.000 |
Why?
|
| United States | 1 | 1992 | 6665 | 0.000 |
Why?
|
| Aged | 1 | 1992 | 18402 | 0.000 |
Why?
|